Navigation Links
DRAXIS Health Reports Results for the First Quarter of 2008
Date:5/9/2008

MONTREAL, May 9 /PRNewswire-FirstCall/ - DRAXIS Health Inc. (TSX: DAX) (NASDAQ: DRAX) reported first quarter financial results for the three months ended March 31, 2008. Revenues and earnings for the first quarter of 2008 were below those in the first quarter of 2007 as a result of lower sales of sterile products, the negative impact of a significantly stronger Canadian dollar relative to the first quarter of 2007, the inclusion in the first quarter of 2007 of non-recurring items and the inclusion in the first quarter of 2008 of the direct and indirect costs related to the potential sale of the Company. All amounts are expressed in U.S. dollars.

Highlights

- Consolidated revenues for the first quarter of 2008 were

$19.2 million versus $21.0 million in the first quarter of 2007.

Product sales in the first quarter of 2008 were $18.7 million,

down 5% from $19.6 million in the first quarter of 2007. Contract

manufacturing sales were down 11%, primarily as a result of lower

revenues from sterile products during the first two months of the

quarter, and radiopharmaceutical sales were up 6%. Product gross

margins for the first quarter of 2008 were impacted by the

stronger Canadian dollar relative to the first quarter of 2007 and

by the change in product mix related to lower sterile product

volumes.

- Operating loss for the first quarter of 2008 was $2.4 million

compared to operating income of $2.5 million in the same period in

2007. Operating income in the first quarter of 2007 benefited from

the receipt of two non-recurring items, namely cont
'/>"/>

SOURCE DRAXIS Health Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
2. DRAXIS to Present at the 2007 UBS Global Life Sciences Conference
3. DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer
4. DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
5. DRAXIS Announces Application for Normal Course Issuer Bid
6. DRAXIS Share Buyback Approved by TSX
7. DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th
8. DRAXIS Health Reports Fourth Quarter and Year End Results
9. DRAXIS Responds to Trading
10. Jubilant to acquire Draxis Health
11. DRAXIS Obtains Interim Order for Proposed Arrangement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... August 30, 2015 , ... Rio Salado College ... serve as the college’s Vice President of Strategic Initiatives and Information Services. O’Shea, who ... help the college expand its reach and impact through innovative technologies and strategies. , ...
(Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... ... one of two inventors from Miller Place, N.Y. "I specialize in manual therapy, ... discomfort. In addition, it can be used for additional muscle dysfunction throughout the ...
(Date:8/29/2015)... ... August 29, 2015 , ... Brands like Toppik , Eau Thermale ... costs. , “Before, a threshold of $49.00 was required to qualify for free standard ... for free standard shipping for customers regardless of the item’s selling price.” , With ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... treating the localized area with stretching, soft tissue manipulation. Platelet rich plasma injections ... have shown through research to improve treatment outcomes. This localized treatment seems ...
(Date:8/28/2015)... ... August 28, 2015 , ... Joining a growing number ... recently transitioned management companies to partner with Wound Care Advantage (WCA) to utilize ... center. , Transitioning wound care management providers can be a complex undertaking. ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4
... Texas Mutual Insurance Company, an,aggressive tort reform advocate ... pending litigation in which the insurance company tried,to overturn ... for a workplace injury,a Dallas state district judge ruled ... falsified medical record,Texas Mutual had no evidence to continue ...
... CHICAGO, Jan. 9 To make your New ... Pretzels(R) (K&SGP) introduces its,Empowered Pretzel(TM), the first of ... healthful twist on the traditional pretzel. The,pretzel is ... http://www.kimandscotts.com or by calling the company at ...
... Health Care,Associates, Inc. (MHA), the nation,s largest alternate ... members, Mr. Barry R. Freedman and,Mr. Brian Wheelan ... and Mr.,Wheelan join seven existing board members representing ... Barry Freedman is President and Chief Executive Officer ...
... GSI Group Inc.,(Nasdaq: GSIG ), a leading ... it will be presenting at both the,Needham & Company ... January,10th and the Fifth Annual Sidoti & Company Emerging ... Mr. Robert Bowen, Chief Financial Officer, will be speaking ...
... Jan. 9 /PRNewswire-FirstCall/ - AlphaRx (OTC BB:ALRX -,News) stated ... of,AlphaRx Inc Common Stock in the open market, bringing ... last 60 days, reflecting his,continued confidence in the Company,s ... of 720,000 AlphaRx shares for,an average price of $0.24 ...
... 2008 Meeting of the American Psychoanalytic Association, psychoanalysts Susan ... Ph.D. (Boston, MA) will lead a discussion regarding "Psychoanalytic ... Dialogue between Psychoanalysis and Neurobiology." This session will be ... 10: 00 pm at the Waldorf-Astoria Hotel, 301 Park ...
Cached Medicine News:Health News:Judge Rules Texas Mutual Insurance Co. Committed Litigation Fraud With Falsified Document, According to Doyle Raizner LLP 2Health News:Kim & Scott's Gourmet Pretzels(R) Introduces Its First Empowered Pretzel(TM) Available Online and to Wholesale 2Health News:MHA Announces: Managed Health Care Associates, Inc. (MHA) Expands Board of Directors 2Health News:MHA Announces: Managed Health Care Associates, Inc. (MHA) Expands Board of Directors 3Health News:GSI to Present at Upcoming Investor Growth Conferences 2
(Date:8/28/2015)... CHAPEL HILL, N.C. , Aug. 28, 2015 ... critical market research projects can slow down the ... costs. It is, therefore, absolutely critical for biopharmaceutical ... the market research approval process for quicker and ... recent research by Best Practices, LLC, nearly three-quarters ...
(Date:8/28/2015)... 2015 Research and ... of the "Investigation Report on China,s Pranoprofen ... Originally discovered by Welfide (Mitsubishi Tanabe Pharma ... as an inflammatory drug, pranoprofen was later developed ... under the trade name of pranopulin for the ...
(Date:8/28/2015)... 2015 Research and Markets ... "Investigation Report on China,s Tobramycin Market, 2010-2019" ... traditional antibiotic whose eye drop and ointment are the ... infection or inflammation caused by eye infection. Currently, dozens ... able to produce tobramycin, among which the Top 5 ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Investigation Report on China's Pranoprofen Market, 2010-2019 2Investigation Report on China's Tobramycin Market, 2015-2019 2
... 2010 Genomic Health, Inc. (Nasdaq: GHDX ) today ... 30, 2010. Total revenue increased to $46.3 million in ... third quarter of 2009.  Product revenue was $45.8 million in the ... $38.9 million in the third quarter of 2009. ...
... Nov. 8, 2010 PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: ... has declared a regular quarterly dividend of $.12 per share ...  The dividend will be payable December 15, 2010, to shareholders ... public in 1984 Mesa Labs has maintained strong cash positions ...
Cached Medicine Technology:Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress 2Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress 3Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress 4Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress 5Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress 6Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress 7Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress 8
... revised charts incorporate the slight change in ... 10 Sloan letters derived from the best ... during the ETDRS study. The original charts ... of 234 eyes. In addition to the ...
... The Stereo Tower is used to ... and adults without the use of ... tests can be used for study, testing ... form and depth perception. The instruction card ...
... to simplify stereopsis screening in children. It is ... gratings. Lang Stereotest II measures disparities: Moon and ... seconds of arc plus monocularly visible star. In ... are smaller and less dense. This disparity is ...
... This "natural" Stereotest consists of three test plates(6mm, ... measurements in a range of 600 - 15 ... shape can only be detected if stereopsis is ... the risk of the patient learning the correct ...
Medicine Products: